The landmark Diabetes Control and Complications Trial (DCCT) [25] showed that intensive insulin treatment could reduce the risk of these complications but at the same time increase the rate of low blood glucose level (hypoglycemia) [26,27], which may lead to acute complications such as seizures and cognitive impairment [28]. Here, INS is linked to diabetes mellitus.